| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
J. Biol. Chem., Vol. 263, Issue 12, 5693-5699, Apr, 1988
AC Johnson, S Ishii, Y Jinno, I Pastan and GT Merlino
To determine the location of sites that may be important for the function
of the promoter of the epidermal growth factor (EGF) receptor gene and to
characterize the factors that bind to these sites, the promoter region was
analyzed by deletion analysis, exonuclease III protection and gel
retardation assays with crude and fractionated nuclear extracts and DNase I
footprinting using purified Sp1. Transfection of chimeric chloramphenicol
acetyltransferase plasmids containing various deletions of the EGF receptor
gene promoter into CV- 1 cells indicated that the region between -178 and
-16 (initiator ATG is +1) is sufficient for promoter activity. Exonuclease
III protection assays revealed the presence of eight specific nuclear
protein binding sites in the region between -481 and -16. Gel retardation
assays confirmed that multiple protein binding sites exist in this region
(- 481 to -16) and quantitatively agree with exonuclease III protection.
DNase I footprinting using purified Sp1 showed that this transcription
factor can bind to four sites (-457 to -440, -365 to -286, -214 to - 200,
and -110 to -84) in the EGF receptor gene promoter and therefore may play a
role in its regulation.
Epidermal growth factor receptor gene promoter. Deletion analysis and identification of nuclear protein binding sites
Laboratory of Molecular Biology, National Cancer Institute, Bethesda, Maryland 20892.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  A. Araujo, R. Ribeiro, I. Azevedo, A. Coelho, M. Soares, B. Sousa, D. Pinto, C. Lopes, R. Medeiros, and G. V. Scagliotti Genetic Polymorphisms of the Epidermal Growth Factor and Related Receptor in Non-Small Cell Lung Cancer--A Review of the Literature Oncologist, February 1, 2007; 12(2): 201 - 210. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. B. de Leon, C. Montanez, P. Gomez, S. L. Morales-Lazaro, V. Tapia-Ramirez, V. Valadez-Graham, F. Recillas-Targa, D. Yaffe, U. Nudel, and B. Cisneros Dystrophin Dp71 Expression Is Down-regulated during Myogenesis: ROLE OF Sp1 AND Sp3 ON THE Dp71 PROMOTER ACTIVITY J. Biol. Chem., February 18, 2005; 280(7): 5290 - 5299. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Liu, F. Innocenti, M. H. Wu, A. A. Desai, M. E. Dolan, E. H. Cook Jr., and M. J. Ratain A Functional Common Polymorphism in a Sp1 Recognition Site of the Epidermal Growth Factor Receptor Gene Promoter Cancer Res., January 1, 2005; 65(1): 46 - 53. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Parakati and J. X. DiMario Sp1- and Sp3-mediated Transcriptional Regulation of the Fibroblast Growth Factor Receptor 1 Gene in Chicken Skeletal Muscle Cells J. Biol. Chem., March 8, 2002; 277(11): 9278 - 9285. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Nishi, K. H. Nishi, and A. C. Johnson Early Growth Response-1 Gene Mediates Up-Regulation of Epidermal Growth Factor Receptor Expression during Hypoxia Cancer Res., February 1, 2002; 62(3): 827 - 834. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Nishi, M. Senoo, K. H. Nishi, B. Murphy, T. Rikiyama, Y. Matsumura, S. Habu, and A. C. Johnson p53 Homologue p63 Represses Epidermal Growth Factor Receptor Expression J. Biol. Chem., November 2, 2001; 276(45): 41717 - 41724. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Salvatori, L. Ravenna, M. P. Felli, M. R. Cardillo, M. A. Russo, L. Frati, A. Gulino, and E. Petrangeli Identification of an Estrogen-Mediated Deoxyribonucleic Acid-Binding Independent Transactivation Pathway on the Epidermal Growth Factor Receptor Gene Promoter Endocrinology, June 1, 2000; 141(6): 2266 - 2274. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Derwahl, M. Broecker, and Z. Kraiem Thyrotropin May Not Be the Dominant Growth Factor in Benign and Malignant Thyroid Tumors J. Clin. Endocrinol. Metab., March 1, 1999; 84(3): 829 - 834. [Full Text]
|
|
|
|
 |
|
 S. Vallian, K.-V. Chin, and K.-S. Chang The Promyelocytic Leukemia Protein Interacts with Sp1 and Inhibits Its Transactivation of the Epidermal Growth Factor Receptor Promoter Mol. Cell. Biol., December 1, 1998; 18(12): 7147 - 7156. [Abstract] [Full Text]
|
|
|
|
|
|
A. L. Reed, H. Yamazaki, J. D. Kaufman, Y. Rubinstein, B. Murphy, and A. C. Johnson Molecular Cloning and Characterization of a Transcription Regulator with Homology to GC-binding Factor J. Biol. Chem., August 21, 1998; 273(34): 21594 - 21602. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Shibutani, P. Lazarovici, A. C. Johnson, Y. Katagiri, and G. Guroff Transcriptional Down-regulation of Epidermal Growth Factor Receptors by Nerve Growth Factor Treatment of PC12 Cells J. Biol. Chem., March 20, 1998; 273(12): 6878 - 6884. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. C. Johnson and A. C. Johnson Activation of Epidermal Growth Factor Receptor Gene Transcription by Phorbol 12-Myristate 13-Acetate Is Mediated by Activator Protein 2 J. Biol. Chem., February 9, 1996; 271(6): 3033 - 3038. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Pagès, E. R. Stanley, M. Le Gall, A. Brunet, and J. Pouysségur The Mouse p44 Mitogen-activated Protein Kinase (Extracellular Signal-regulated Kinase 1) Gene J. Biol. Chem., November 10, 1995; 270(45): 26986 - 26992. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Chin, K Ueda, I Pastan, and M. Gottesman Modulation of activity of the promoter of the human MDR1 gene by Ras and p53 Science, January 24, 1992; 255(5043): 459 - 462. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |
